Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection

por Lam, Simon W., Athans, Vasilios
Publicado en Antimicrob Agents Chemother (2019)

Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis

por Lam, Simon W., Bauer, Seth R.
Publicado 2013

Did the beneficial renal outcomes with vasopressin VANISH?

por Sacha, Gretchen L., Lam, Simon W., Bauer, Seth R.
Publicado en Ann Transl Med (2016)

Impact of Combination Antimicrobial Therapy on Mortality Risk for Critically Ill Patients with Carbapenem-Resistant Bacteremia

por Bass, Stephanie N., Bauer, Seth R., Neuner, Elizabeth A., Lam, Simon W.
Publicado en Antimicrob Agents Chemother (2015)

Comparison of Interventions Made in an Ambulatory Pharmacist-Managed Refill Model to Usual Physician Care

por Okraszewski, Stephanie, Sattler-Leja, Rebecca, Brodman, Monika, Goll, David, Lam, Simon W.
Publicado en J Pharm Technol (2019)

Engaging in Collaborative Research: Focus on the Pharmacy Practitioner

por Badowski, Melissa, Mazur, Joseph E., Lam, Simon W., Miyares, Marta, Schulz, Lucas, Michienzi, Sarah
Publicado en Hosp Pharm (2017)

Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli

por Gibson, Gabrielle A., Bauer, Seth R., Neuner, Elizabeth A., Bass, Stephanie N., Lam, Simon W.
Publicado en Antimicrob Agents Chemother (2015)

Characterizing Critical Care Pharmacy Services Across the United States

por MacLaren, Robert, Roberts, Russel J., Dzierba, Amy L., Buckley, Mitchell, Lat, Ishaq, Lam, Simon W.
Publicado en Crit Care Explor (2021)

Ketamine Safety and Use in the Emergency Department for Pain and Agitation/Delirium: A Health System Experience

por Mo, Hanjie, Campbell, Matthew J., Fertel, Baruch S., Lam, Simon W., Wells, Elizabeth J., Casserly, Elizabeth, Meldon, Stephen W.
Publicado en West J Emerg Med (2020)

Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose

por Eschenauer, Gregory A., Carver, Peggy L., Patel, Twisha S., Lin, Shu-Wen, Klinker, Kenneth P., Pai, Manjunath P., Lam, Simon W.
Publicado en Antimicrob Agents Chemother (2018)

Predictors of response to fixed-dose vasopressin in adult patients with septic shock

por Sacha, Gretchen L., Lam, Simon W., Duggal, Abhijit, Torbic, Heather, Bass, Stephanie N., Welch, Sarah C., Butler, Robert S., Bauer, Seth R.
Publicado en Ann Intensive Care (2018)

Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock

por Yerke, Jason R., Sacha, Gretchen L., Scheraga, Rachel G., Culver, Daniel A., Abraham, Susamma, Torbic, Heather, Lam, Simon W., Ammar, Mahmoud A., Olman, Mitchell A., Bauer, Seth R.
Publicado en Pharmacotherapy (2019)

Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study

por Eschenauer, Gregory A., Carver, Peggy L., Lin, Shu-Wen, Klinker, Kenneth P., Chen, Yee-Chun, Potoski, Brian A., Shields, Ryan K., Clancy, Cornelius J., Nguyen, Minh-Hong, Lam, Simon W.
Publicado 2013

Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates

por Eschenauer, Gregory A., Nguyen, M. Hong, Shoham, Shmuel, Vazquez, Jose A., Morris, Arthur J., Pasculle, William A., Kubin, Christine J., Klinker, Kenneth P., Carver, Peggy L., Hanson, Kimberly E., Chen, Sharon, Lam, Simon W., Potoski, Brian A., Clarke, Lloyd G., Shields, Ryan K., Clancy, Cornelius J.
Publicado 2014